Fig. 4From: Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysisComparison of mean PAI-1 antigen levels (ng/mL) in patients with primary and secondary major adverse cardiac events and control patients. Data is expressed as a mean difference and analyzed using a random effects model. a PAI-1 levels (ng/mL) in patients with primary major adverse cardiac events. b PAI-1 levels (ng/mL) in patients with secondary major adverse cardiac eventsBack to article page